Pfizer scraps twice-daily weight loss pill danuglipron after study shows ‘high rates’ of adverse side effects
Pfizer is shelving development of a twice-daily version of its weight loss drug after a trial proved users reported high rates of adverse side effects.
Walgreens resolves COVID-19 vaccine supply after appointment challenges
Walgreens announced that its pharmacies across the country now have COVID-19 vaccine supplies and additional appointments available in response to ongoing disruptions.
Narcan nasal spray is available for over-the-counter purchase in US: ‘Lifesaving drug’
Narcan (naloxone) is now available for purchase over the counter (OTC), without a prescription, in all U.S. states, Washington, D.C. and Puerto Rico. Here are details.
What the 10 drugs subject to Medicare price negotiations currently cost
President Biden announced the first 10 Medicare Part D drugs his administration has selected for price negotiation, including blood thinner Eliquis and Jardiance, a diabetes medication.
Amazon, Mark Cuban drug company partner with Blue Shield of California to overhaul prescription drug system
Blue Shield of California is working with Amazon and Mark Cuban's drug company to transform the prescription drug system, which rewards stakeholders for selling higher priced drugs.
Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi launch
Biogen said on Tuesday it expects to eliminate roughly 1,000 positions in the U.S. to save money ahead of launching a new drug to treat Alzheimer's disease.
Alzheimer’s drug Leqembi: What to know
Alzheimer’s drug Leqembi received full approval from the U.S. Food and Drug Administration. An expert explains why this is a milestone in the treatment of the progressive disease.
TikTok users calling berberine 'nature's Ozempic' but is it?
TikTok users have been testing out berberine, which is an herbal supplement, that is gaining popularity for its alleged weight loss effects.
AI is already speeding up drug development and reducing animal testing
AI-driven technology developed by VeriSIM Life accelerates drug development and reduces the need for animal testing by analyzing pharmaceuticals before human trials.
AI and machine learning may speed drug development, manufacturing: FDA
The FDA published two discussion papers this week about areas artificial intelligence and machine learning may improve drug development and manufacturing processes.
FDA debates health risks of birth control without prescription
The FDA may approve birth control pills over-the-counter by the summer, but expressed hesitation due to concerns over women misreading labels on the drug's health concerns.
Diabetes drug tested for weight loss could be game changer
Eli Lilly's tirzepatide, which is approved to treat Type 2 diabetes and sold under the brand name Mounjaro, could become the most effective weight loss treatment.
Narcan maker aims to make overdose reversal drug more affordable, company says
Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.
Bayer plans to shift focus away from women’s health drug research
Bayer has announced plans to shift its efforts away from women’s health to focus on diseases, cardiovascular disease, neurology, oncology and immunology.
FDA says it's 'working to address' shortage of albuterol product used in hospitals
There is a scarcity of a certain albuterol medication product – and the Food and Drug Administration said Wednesday night that it is "working to address" that.
SOTU: Biden pushes for insulin cost caps
In Tuesday night's State of the Union Address, President Biden called for a cap on the price of insulin.
Narcan maker gets fast-tracked for over-the-counter nasal spray
FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.
FDA takes tougher line on fast-tracked drugs
The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.
Opioid crisis: New Hampshire strikes $40.5 million settlement with Johnson & Johnson
New Hampshire Attorney General John Formella announced that the state reached a $40.5 million settlement with Johnson & Johnson over opioid claims on Thursday.
West Virginia reaches $400 million settlement with opioid distributors
West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp.